Is M&A about to heat up in the biotech space? Les Funtleyder, of Miller Tabak, and Seamus Fernandez, of Leerink Swann, share there thoughts on this and their stock picks.
Peter Boockvar, equities strategist at Miller Tabak & Co., says uncertainties over policy changes from Washington are hindering companies' long-term investment decisions. He shares his views, with CNBC's Martin Soong, Karen Tso and Sri Jegarajah.
The U.S. economy is slowing down and the earnings season will reflect limited visibility for companies in the second half, says Peter Boockvar, equities strategist at Miller Tabak & Co. He talks to CNBC's Martin Soong, Karen Tso and Sri Jegarajah.
Looking ahead in the markets, with Tony Crescenzi, Pimco Sr. VP, Market Strategist & Portfolio Manager and Dan Greenhaus, Miller Tabak + Co. Chief Economic Strategist.
What to expect from this month's employment numbers, with Mark Zandi, Moody's Analytics; Dan Greenhaus, Miller Tabak; Bob Barbera, ITG; and CNBC's Steve Liesman.
The uncertainty surrounding the US financial reform bill is causing nervousness in the markets, Dan Greenhaus from Miller Tabak said Thursday. The turnaround in the proposed dropping derivatives operations spinout is encouraging, he added.
There are headwinds coming "over the hill" for the economy, Dan Greenhaus from Miller Tabak told CNBC Thursday. The unwinding of Fed policy could cause disruption, he added.
Fed Chief's Impact on Wall Street: Dan Greenhaus, chief economic strategist at Miller Tabak, on what Wall Street needs to hear from Federal Reserve Chief Ben Bernanke.
Treasury will auction $21 billion of 10-year notes Wednesday. Steve Wieting, of Citigroup; Dan Greenhaus, of Miller Tabak; Byron Wien, of Blackstone; and CNBC's Steve Liesman discuss.
The Market Rebound: The blue-chip rally has been making a slow and steady push, but will this push continue? Patricia Chadwick, of Ravengate Partners; Dan Greenhaus, of Miller Tabak; and Tony Crescenzi, of Pimco, share their insight.
